Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 19;11(1):e210020.
doi: 10.1530/ETJ-21-0020.

Diffuse sclerosing variant of papillary thyroid carcinoma: outcomes of 33 cases

Affiliations

Diffuse sclerosing variant of papillary thyroid carcinoma: outcomes of 33 cases

Daniela Cavaco et al. Eur Thyroid J. .

Abstract

Introduction: Diffuse sclerosing variant of PTC (DSV-PTC) is an uncommon subtype of thyroid cancer. Although an aggressive behavior is often recognized, prognostic significance is still under debate.

Objectives: To describe the clinicopathological features and outcomes of a series of DSV-PTC patients.

Methods: Retrospective data collection involving 33 patients diagnosed with DSV-PTC followed at the Endocrine Department of the Portuguese Institute of Oncology in Lisbon between 1981 and 2020.

Results: Twenty-six patients (78.8%) were females with a mean age at presentation of 29.4 ± 11.7 years old. Mean time of follow-up was 19.5 ± 10.6 years (range 0.5-39). Histologically, bilateral tumors were present in 72.7% patients (n = 24), thyroid capsular invasion was documented in 57.6% (n = 19), 45.4% (n = 15) had extrathyroidal extension, and 42.4% (n = 14) had lymphovascular invasion. Most patients were staged pT3 (42.4%, n = 14) and pN1 (81.8%, n = 27). Median lymph nodes resected were 16. None of the patients showed distant metastases at presentation. All patients were treated at least once with 131I. During follow-up, four patients (14.8%), with persistent neck disease, were diagnosed with distant metastases, all of them in the lung. Two patients (1.8%) presented recurrent disease in the neck after being considered with no evidence of disease. At the last appointment, 18 patients (54.5%) were in remission, 4 (12.1%) had biochemical evidence of disease, 6 had structural disease, and for 5 patients disease status was considered as undetermined. There was no disease related mortality.

Discussion/conclusion: Our study confirms that DSV-PTC is diagnosed more often in young patients and exhibits a local extensive disease at presentation. On the other hand, even in the presence of distant metastases, no patient died during follow-up.

Keywords: aggressive thyroid; diffuse sclerosing variant; papillary thyroid carcinoma.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A 19-year-old male with diffuse sclerosing variant of papillary carcinoma of the thyroid gland with scattered microcalcifications throughout the thyroid gland.
Figure 2
Figure 2
A diffuse pattern of infiltration, with fibrosis and lymphocytic infiltrate is apparent on low power view.
Figure 3
Figure 3
Magnififed view of an area of a diffuse sclerosing variant of papillary thyroid carcinoma: there is a diffuse infiltration of thyroid tissue with bands of fibrous tissue, lymphocytic infiltrate, numerous psammoma bodies and focal squamous metaplasia.

References

    1. Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngology: Head and Neck Surgery 2014140317–322. (10.1001/jamaoto.2014.1) - DOI - PubMed
    1. Lloyd RV, Buehler D, Khanafshar E. Papillary thyroid carcinoma variants. Head and Neck Pathology 2011551–56. (10.1007/s12105-010-0236-9) - DOI - PMC - PubMed
    1. LiVolsi VA, Albores-Saavedra J, Asa SL. Papillary carcinoma. In WHO Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs, p. 5766. Eds Lellis D, Lloyd R, Heitz PU, Eng C. Lyon, France: IARC Press, 2004.
    1. Pusztaszeri M, Auger M. Update on the cytologic features of papillary thyroid carcinoma variants. Diagnostic Cytopathology 201745714–730. (10.1002/dc.23703) - DOI - PubMed
    1. Malandrino P, Russo M, Regalbuto C, Pellegriti G, Moleti M, Caff A, Squatrito S, Vigneri R. Outcome of the diffuse sclerosing variant of papillary thyroid cancer: a meta-analysis. Thyroid 2016261285–1292. (10.1089/thy.2016.0168) - DOI - PubMed